132 related articles for article (PubMed ID: 29893543)
1. Role of Hydrophobicity and Charge of Amyloid-Beta Oligomer Eliminating d-Peptides in the Interaction with Amyloid-Beta Monomers.
Ziehm T; Buell AK; Willbold D
ACS Chem Neurosci; 2018 Nov; 9(11):2679-2688. PubMed ID: 29893543
[TBL] [Abstract][Full Text] [Related]
2. Toward the Mode of Action of the Clinical Stage All-d-Enantiomeric Peptide RD2 on Aβ42 Aggregation.
Zhang T; Gering I; Kutzsche J; Nagel-Steger L; Willbold D
ACS Chem Neurosci; 2019 Dec; 10(12):4800-4809. PubMed ID: 31710458
[TBL] [Abstract][Full Text] [Related]
3. Optimization of d-Peptides for Aβ Monomer Binding Specificity Enhances Their Potential to Eliminate Toxic Aβ Oligomers.
Klein AN; Ziehm T; van Groen T; Kadish I; Elfgen A; Tusche M; Thomaier M; Reiss K; Brener O; Gremer L; Kutzsche J; Willbold D
ACS Chem Neurosci; 2017 Sep; 8(9):1889-1900. PubMed ID: 28581708
[TBL] [Abstract][Full Text] [Related]
4. Increase of Positive Net Charge and Conformational Rigidity Enhances the Efficacy of d-Enantiomeric Peptides Designed to Eliminate Cytotoxic Aβ Species.
Ziehm T; Brener O; van Groen T; Kadish I; Frenzel D; Tusche M; Kutzsche J; Reiß K; Gremer L; Nagel-Steger L; Willbold D
ACS Chem Neurosci; 2016 Aug; 7(8):1088-96. PubMed ID: 27240424
[TBL] [Abstract][Full Text] [Related]
5. Large-Scale Oral Treatment Study with the Four Most Promising D3-Derivatives for the Treatment of Alzheimer's Disease.
Kutzsche J; Schemmert S; Tusche M; Neddens J; Rabl R; Jürgens D; Brener O; Willuweit A; Hutter-Paier B; Willbold D
Molecules; 2017 Oct; 22(10):. PubMed ID: 28994710
[TBL] [Abstract][Full Text] [Related]
6. Destabilization of β-amyloid aggregates by thrombin derived peptide: plausible role of thrombin in neuroprotection.
De D; Bhattacharjee P; Das H; Kumar KS; Biswas SC; Bhattacharyya D
FEBS J; 2020 Jun; 287(11):2386-2413. PubMed ID: 31747135
[TBL] [Abstract][Full Text] [Related]
7. Amyloid-β Peptide Interactions with Amphiphilic Surfactants: Electrostatic and Hydrophobic Effects.
Österlund N; Kulkarni YS; Misiaszek AD; Wallin C; Krüger DM; Liao Q; Mashayekhy Rad F; Jarvet J; Strodel B; Wärmländer SKTS; Ilag LL; Kamerlin SCL; Gräslund A
ACS Chem Neurosci; 2018 Jul; 9(7):1680-1692. PubMed ID: 29683649
[TBL] [Abstract][Full Text] [Related]
8. Differently selected D-enantiomeric peptides act on different Abeta species.
Bartnik D; Funke SA; Andrei-Selmer LC; Bacher M; Dodel R; Willbold D
Rejuvenation Res; 2010; 13(2-3):202-5. PubMed ID: 19954333
[TBL] [Abstract][Full Text] [Related]
9. Interaction of Therapeutic d-Peptides with Aβ42 Monomers, Thermodynamics, and Binding Analysis.
Leguizamon Herrera VL; Buell AK; Willbold D; Barz B
ACS Chem Neurosci; 2022 Jun; 13(11):1638-1650. PubMed ID: 35580288
[TBL] [Abstract][Full Text] [Related]
10. Amyloid aggregation inhibitory mechanism of arginine-rich D-peptides.
Olubiyi OO; Frenzel D; Bartnik D; Glück JM; Brener O; Nagel-Steger L; Funke SA; Willbold D; Strodel B
Curr Med Chem; 2014; 21(12):1448-57. PubMed ID: 24304283
[TBL] [Abstract][Full Text] [Related]
11. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library.
Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN
Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663
[TBL] [Abstract][Full Text] [Related]
12. Structural, morphological, and kinetic studies of β-amyloid peptide aggregation on self-assembled monolayers.
Wang Q; Shah N; Zhao J; Wang C; Zhao C; Liu L; Li L; Zhou F; Zheng J
Phys Chem Chem Phys; 2011 Sep; 13(33):15200-10. PubMed ID: 21769359
[TBL] [Abstract][Full Text] [Related]
13. Aβ Oligomer Elimination Restores Cognition in Transgenic Alzheimer's Mice with Full-blown Pathology.
Schemmert S; Schartmann E; Zafiu C; Kass B; Hartwig S; Lehr S; Bannach O; Langen KJ; Shah NJ; Kutzsche J; Willuweit A; Willbold D
Mol Neurobiol; 2019 Mar; 56(3):2211-2223. PubMed ID: 30003517
[TBL] [Abstract][Full Text] [Related]
14. Engineering of a peptide probe for β-amyloid aggregates.
Aoraha E; Candreva J; Kim JR
Mol Biosyst; 2015 Aug; 11(8):2281-9. PubMed ID: 26073444
[TBL] [Abstract][Full Text] [Related]
15. Competitive Mirror Image Phage Display Derived Peptide Modulates Amyloid Beta Aggregation and Toxicity.
Rudolph S; Klein AN; Tusche M; Schlosser C; Elfgen A; Brener O; Teunissen C; Gremer L; Funke SA; Kutzsche J; Willbold D
PLoS One; 2016; 11(2):e0147470. PubMed ID: 26840229
[TBL] [Abstract][Full Text] [Related]
16. Peptides, Peptidomimetics, and Carbohydrate-Peptide Conjugates as Amyloidogenic Aggregation Inhibitors for Alzheimer's Disease.
Ryan P; Patel B; Makwana V; Jadhav HR; Kiefel M; Davey A; Reekie TA; Rudrawar S; Kassiou M
ACS Chem Neurosci; 2018 Jul; 9(7):1530-1551. PubMed ID: 29782794
[TBL] [Abstract][Full Text] [Related]
17. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
Matsuzaki K
Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of amyloid-β aggregation in Alzheimer's disease.
Wang Q; Yu X; Li L; Zheng J
Curr Pharm Des; 2014; 20(8):1223-43. PubMed ID: 23713775
[TBL] [Abstract][Full Text] [Related]
19. The N-methylated peptide SEN304 powerfully inhibits Aβ(1-42) toxicity by perturbing oligomer formation.
Amijee H; Bate C; Williams A; Virdee J; Jeggo R; Spanswick D; Scopes DI; Treherne JM; Mazzitelli S; Chawner R; Eyers CE; Doig AJ
Biochemistry; 2012 Oct; 51(42):8338-52. PubMed ID: 23025847
[TBL] [Abstract][Full Text] [Related]
20. A discrete mathematical model for the aggregation of β-Amyloid.
Dayeh MA; Livadiotis G; Elaydi S
PLoS One; 2018; 13(5):e0196402. PubMed ID: 29791461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
